Hulse William Frank IV 4

What Happened

William Frank Hulse IV, General Counsel and Chief Accounting Officer of MIMEDX Group, received two equity awards on March 4, 2026: 74,987 restricted shares granted at $0 and a derivative award covering 62,758 shares (also $0). The grants were reported on a Form 4 filed March 6, 2026. No cash was paid — these were compensation awards, not open-market purchases or sales.

Key Details

• Transaction date: 2026-03-04; Filing date: 2026-03-06 (appears timely under the two-business-day Form 4 rule).
• Grants: 74,987 restricted shares @ $0; 62,758-share derivative award @ $0. Total shares granted: 137,745.
• Shares owned after the transaction: not disclosed in the provided filing excerpt.
• Footnotes:
  • F1 — The 74,987 restricted shares vest fully on the third anniversary of the grant, subject to continued employment.
  • F2 — The derivative award is an option-like grant that vests 25% on each anniversary of the grant date, subject to continued employment.
• No 10b5-1 plan, tax-withholding sale, or immediate sale/exercise noted in the filing excerpt.

Context

These are compensation grants (awards), which are routine for executives and do not represent open-market buying or selling. The restricted shares require continued employment for full vesting; the derivative/option-style award vests over four years (25% per year). Such awards indicate company compensation decisions rather than an immediate trading signal.